On April 17, 2013, Shenzhen held the "Ultrasound Cirrhosis Tester Listing Press Conference". At the meeting, the first ultrasonic liver cirrhosis diagnostic instrument independently developed by China was officially launched. The advent of this instrument means that in the future ultrasound cirrhosis diagnostic market, China's independently developed ultrasound cirrhosis testing equipment successfully breaks through foreign technical barriers and breaks the monopoly of foreign equipment. According to the introduction of Shenzhen Advanced Technology Research Institute, this instrument was jointly developed by the Ultrasound Elastography R & D team of Advanced Institute and Integrated Medical. During the R & D process, the R & D team has overcome a number of difficult problems such as ultrasound transient elastography, high-sensitivity weak signal processing and other electronic and electronic systems to form an ultrasound cirrhosis detector product with independent intellectual property rights. He has undertaken a number of national science and technology plan projects, has 11 authorized patents and 1 international trademark registration, and related technologies have filled many domestic gaps. China is a major liver disease country, and cirrhosis diagnostic equipment is still in the blank in Asia. Many patients with cirrhosis cannot be found in the early stage, which delays the optimal treatment time. The traditional cirrhosis test uses puncture sampling, which requires high detection technology and will cause trauma to the patient during the test. Therefore, doctors and patients want a non-invasive detection method. According to the introduction of the medical director of integrated medical, the newly developed ultrasonic cirrhosis detector uses the principle of sound wave transmission rate and tissue hardness to measure the hardness of liver tissue, so as to judge the degree of liver fibrosis. It is a noninvasive, fast and There are better repeatability of liver fibrosis and cirrhosis quantitative detection equipment. It is reported that this liver disease diagnostic instrument project is the latest industry-university-research result developed by the Shenzhen Advanced Hospital of the Chinese Academy of Sciences and Shenzhen One Medical Technology Co., Ltd. after more than three years of pre-research, product development, debugging, and clinical testing. The enterprise completes the interpretation of transformation and upgrading through technological innovation. Ningbo XISXI E-commerce Co., Ltd , https://www.petspetsdoggze.com